Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Pharmacogenomics|August 2, 2014
Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for cliniciansGwyneth Zai, Eva J Brandl, Daniel J Müller, et al.Frontiers in Psychiatry|June 14, 2021
The Differential Impact of Lockdown Measures Upon Migrant and Female Psychiatric Patients - A Cross-Sectional Survey in a Psychiatric Hospital in Berlin, GermanyJames K Moran, Joachim Bretz, Johanna Winkler, et al.Frontiers in Human Neuroscience|October 21, 2015
Linking unfounded beliefs to genetic dopamine availabilityKatharina Schmack, Hannes Rössler, Maria Sekutowicz, et al.Neuropsychobiology|November 1, 2016
Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia PatientsGeorge Bakanidze, Eva J Brandl, Christine Hutzler, et al.Psychiatrische Praxis|January 24, 2018
[Clinical and sociodemographic Differences Between Patients with and without Migration Background in a Psychiatric Outpatient Service]Eva J Brandl, Nora Dietrich, Nicoleta Mell, et al.Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 28, 2022
Trail Making Test Error Analysis in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Dementia With and Without DepressionNicklas J Hafiz, Andrea Lohse, Rico Haas, et al.BMC Psychiatry|April 19, 2020
Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration backgroundEva J Brandl, Nora Dietrich, Nicoleta Mell, et al.Psychiatry Research|April 28, 2018
Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medicationLucas M Walden, Eva J Brandl, Arun K Tiwari, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 25, 2014
Genetic variation in CYP3A43 is associated with response to antipsychotic medicationEva J Brandl, Nabilah I Chowdhury, Arun K Tiwari, et al.Drugs & Aging|September 8, 2023
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-AnalysisNadine Bittner, Cleo S M Funk, Alexander Schmidt, et al.Pageof 5